Roedovre, Denmark

Alice Ravn Madsen

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Alice Ravn Madsen

Introduction

Alice Ravn Madsen is a notable inventor based in Roedovre, Denmark. She has made significant contributions to the field of diabetes treatment through her innovative patents. With a total of two patents, her work focuses on developing advanced insulin derivatives and GLP-1 analogs.

Latest Patents

Her latest patents include "Glucose sensitive insulins and uses thereof," which provides glucose-sensitive insulin derivatives that comprise a macrocycle, a glucose mimetic, and human insulin or an analogue thereof. This invention also relates to pharmaceutical compositions that utilize these derivatives for treating or preventing medical conditions associated with diabetes. Another significant patent is for "Double-acylated GLP-1 derivatives," which describes a derivative of a GLP-1 analog with specific amino acid modifications. This invention is aimed at the treatment and prevention of various forms of diabetes and related diseases, with derivatives suitable for oral administration.

Career Highlights

Alice has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S and Ziylo Limited. Her experience in these organizations has contributed to her expertise in developing innovative solutions for diabetes management.

Collaborations

Alice has collaborated with notable professionals in her field, including Per Sauerberg and Thomas Kruse. These collaborations have further enhanced her research and development efforts.

Conclusion

Alice Ravn Madsen's contributions to diabetes treatment through her innovative patents highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in medical treatments for diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…